FDA approves leucovorin for brain folate deficiency, but not autism
The Food and Drug Administration on Tuesday approved a decades-old prescription vitamin called leucovorin as the first treatment for a…
Biotechnology and pharmaceuticals
Novo Nordisk ends legal proceedings against Hims & Hers
Nordisk has dropped its legal case against telehealth provider him and her for patent infringement, after the two companies agreed…
FDA Reversals on UniQure, Moderna Approvals Worry Investors
Investors are concerned about the fate of multiple experimental drugs for difficult-to-treat diseases following a series of recent rejections by…
Eli Lilly Launches Program to Increase Employer Coverage of Obesity Drugs
Eli Lilly On Thursday it launched a new program designed to help more employers cover obesity medications in the U.S.,…
Why Novo Nordisk's expansion in Ireland is key to fighting Eli Lilly
Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production capabilities to…
What's next for Novo Nordisk's anti-obesity drug CagriSema?
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Novo Nordisk to cut US list prices for Wegovy and Ozempic by up to 50%
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, on February…
Eli Lilly launches anti-obesity drug Zepbound with one-month dosage
An Eli Lilly & Co. Zepbound injection pen placed in the Brooklyn borough of New York on March 28, 2024.…
Novo Nordisk Shares Fall as Weight Loss Drug Fails to Beat Eli Lilly
The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, November 5, 2025. Nichlas Pollier | Bloomberg | fake images…
More medications should be available over the counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over-the-counter” unless a drug is…